Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells
- PMID: 8287600
- PMCID: PMC1534619
- DOI: 10.1111/j.1365-2249.1994.tb06029.x
Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells
Abstract
It has previously been shown that murine sarcoma cells express high-affinity IL-4 receptors (IL-4R) which are internalized after binding to the ligand (Puri et al., Cancer Res 1991; 51:3011-7). We have also reported that human renal cell carcinoma cells express high-affinity IL-4R, and IL-4 inhibits tumour growth in vitro (Obiri et al., J Clin Invest 1993; 91:88). In this study we investigated the expression and function of IL-4R on other human solid tumours. Human melanoma, ovarian carcinoma and breast carcinoma cell lines were assessed for the cell surface expression of IL-4R by radio-ligand receptor binding and for IL-4R gene expression by Northern blot analysis. Primary cultures of mesothelioma and neurofibrosarcoma cells were similarly investigated. Human melanoma, ovarian carcinoma and breast carcinoma cell lines expressed IL-4R on their cell surface with a dissociation constant (Kd) of 140-549 pM. These tumour lines expressed a single 4 kb species of mRNA for IL-4R. Similarly, primary cultures of mesothelioma and neurofibrosarcoma cells were positive for the IL-4R mRNA by Northern blot analysis. Fresh, non-cultured mesothelioma and neurofibrosarcoma tumour sections were also positive for the presence of IL-4R as determined by immunohistochemistry of frozen sections using anti-IL-4R antibody. In order to study possible functions of IL-4R, we evaluated the effects of IL-4 on cell growth and its effect on MHC antigen expression in the presence or absence of interferon-gamma (IFN-gamma). In tissue culture, IL-4 reduced the growth of tumour cell lines and primary cell cultures studied. IL-4 had very little effect on MHC class I antigen expression on ovarian, breast and melanoma cell lines; however, MHC class II (HLA-DR) expression was enhanced on melanoma and breast carcinoma cells. IL-4 also enhanced the IFN-gamma-induced class II expression on melanoma and breast carcinoma cells. Taken together, our observations indicate that IL-4R are expressed on a variety of human solid tumours and these receptors may be functional. IL-4 alone and in combination with IFN-gamma may play a role in host immune response against cancers.
Similar articles
-
Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.J Clin Invest. 1993 Jan;91(1):88-93. doi: 10.1172/JCI116205. J Clin Invest. 1993. PMID: 8423237 Free PMC article.
-
Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.Clin Exp Immunol. 1994 Jun;96(3):476-83. doi: 10.1111/j.1365-2249.1994.tb06054.x. Clin Exp Immunol. 1994. PMID: 8004818 Free PMC article.
-
Interleukin 4 receptor expression and growth inhibition of gastric carcinoma cells by interleukin 4.Cancer Res. 1992 Nov 1;52(21):6059-65. Cancer Res. 1992. PMID: 1394231
-
A review of studies on targeting interleukin 4 receptor for central nervous system malignancy.Curr Mol Med. 2009 Aug;9(6):732-9. doi: 10.2174/156652409788970661. Curr Mol Med. 2009. PMID: 19689300 Review.
-
In vivo biological effects of recombinant soluble interleukin-4 receptor.Proc Soc Exp Biol Med. 1994 Jul;206(3):233-7. doi: 10.3181/00379727-206-43750. Proc Soc Exp Biol Med. 1994. PMID: 8016157 Review.
Cited by
-
Development of elastin-like polypeptide for targeted specific gene delivery in vivo.J Nanobiotechnology. 2020 Jan 17;18(1):15. doi: 10.1186/s12951-020-0574-z. J Nanobiotechnology. 2020. PMID: 31952530 Free PMC article.
-
Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines.Front Immunol. 2019 Feb 20;10:263. doi: 10.3389/fimmu.2019.00263. eCollection 2019. Front Immunol. 2019. PMID: 30842774 Free PMC article. Review.
-
Combination of metformin and curcumin targets breast cancer in mice by angiogenesis inhibition, immune system modulation and induction of p53 independent apoptosis.Ther Adv Med Oncol. 2017 Apr;9(4):235-252. doi: 10.1177/1758834016687482. Epub 2017 Feb 1. Ther Adv Med Oncol. 2017. PMID: 28491145 Free PMC article.
-
Designed ferritin nanocages displaying trimeric TRAIL and tumor-targeting peptides confer superior anti-tumor efficacy.Sci Rep. 2020 Nov 17;10(1):19997. doi: 10.1038/s41598-020-77095-x. Sci Rep. 2020. PMID: 33203916 Free PMC article.
-
Construction and application of elastin like polypeptide containing IL-4 receptor targeting peptide.PLoS One. 2013 Dec 10;8(12):e81891. doi: 10.1371/journal.pone.0081891. eCollection 2013. PLoS One. 2013. PMID: 24339977 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials